BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PCM1, Q15154, PTC4, ENSG00000078674, 5108
10 results:

  • 1. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors.
    Kruslin B; Gatalica Z; Hes O; Skenderi F; Miettinen M; Contreras E; Xiu J; Ellis M; Florento E; Vranic S; Swensen J
    Clin Genitourin Cancer; 2021 Aug; 19(4):333-338. PubMed ID: 33741265
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Height and Breast cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.
    Zhang B; Shu XO; Delahanty RJ; Zeng C; Michailidou K; Bolla MK; Wang Q; Dennis J; Wen W; Long J; Li C; Dunning AM; Chang-Claude J; Shah M; Perkins BJ; Czene K; Darabi H; Eriksson M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Lambrechts D; Neven P; Wildiers H; Floris G; Schmidt MK; Rookus MA; van den Hurk K; de Kort WL; Couch FJ; Olson JE; Hallberg E; Vachon C; Rudolph A; Seibold P; Flesch-Janys D; Peto J; Dos-Santos-Silva I; Fletcher O; Johnson N; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Li J; Humphreys K; Brand J; Guénel P; Truong T; Cordina-Duverger E; Menegaux F; Burwinkel B; Marme F; Yang R; Surowy H; Benitez J; Zamora MP; Perez JI; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Chenevix-Trench G; ; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Lindblom A; Margolin S; Hooning MJ; Martens JW; Tilanus-Linthorst MM; Collée JM; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Giles GG; Milne RL; McLean C; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Swerdlow AJ; Ashworth A; Orr N; Jones M; Figueroa J; Garcia-Closas M; Brinton L; Lissowska J; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Brauch H; Brüning T; Ko YD; Peterlongo P; Manoukian S; Bonanni B; Radice P; Bogdanova N; Antonenkova N; Dörk T; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubiński J; Jaworska-Bieniek K; Durda K; Hamann U; Torres D; Schmutzler RK; Neuhausen SL; Anton-Culver H; Kristensen VN; Grenaker Alnæs GI; ; Pierce BL; Kraft P; Peters U; Lindstrom S; Seminara D; Burgess S; Ahsan H; Whittemore AS; John EM; Gammon MD; Malone KE; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; González-Neira A; Pita G; Alonso MR; Álvarez N; Herrero D; Pharoah PD; Simard J; Hall P; Hunter DJ; Easton DF; Zheng W
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26296642
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.
    Chen X; Paranjape T; Stahlhut C; McVeigh T; Keane F; Nallur S; Miller N; Kerin M; Deng Y; Yao X; Zhao H; Weidhaas JB; Slack FJ
    Oncogene; 2015 Apr; 34(16):2125-37. PubMed ID: 24909162
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.
    Charpentier AM; Chong AL; Gingras-Hill G; Ahmed S; Cigsar C; Gupta AA; Greenblatt E; Hodgson DC
    J Cancer Surviv; 2014 Dec; 8(4):548-54. PubMed ID: 24810980
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohort.
    Saxena R; Bjonnes A; Prescott J; Dib P; Natt P; Lane J; Lerner M; Cooper JA; Ye Y; Li KW; Maubaret CG; Codd V; Brackett D; Mirabello L; Kraft P; Dinney CP; Stowell D; Peyton M; Ralhan S; Wander GS; Mehra NK; Salpea KD; Gu J; Wu X; Mangino M; Hunter DJ; De Vivo I; Humphries SE; Samani NJ; Spector TD; Savage SA; Sanghera DK
    Circ Cardiovasc Genet; 2014 Jun; 7(3):287-95. PubMed ID: 24795349
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies.
    Chinn DC; Holland WS; Mack PC
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1137-49. PubMed ID: 24756365
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway.
    Chefetz I; Holmberg JC; Alvero AB; Visintin I; Mor G
    Cell Cycle; 2011 Jul; 10(13):2206-14. PubMed ID: 21623171
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
    Hahn HS; Yoon SG; Hong JS; Hong SR; Park SJ; Lim JY; Kwon YS; Lee IH; Lim KT; Lee KH; Shim JU; Mok JE; Kim TJ
    Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival.
    Pils D; Horak P; Gleiss A; Sax C; Fabjani G; Moebus VJ; Zielinski C; Reinthaller A; Zeillinger R; Krainer M
    Cancer; 2005 Dec; 104(11):2417-29. PubMed ID: 16270321
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sequential granulocyte colony-stimulating factor increases cisplatin cytotoxicity in human epithelial ovarian cancer cell lines.
    Fanning J; Hilgers RD; Kane C; Medrano C
    Gynecol Oncol; 1996 Mar; 60(3):450-3. PubMed ID: 8774656
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.